HIV and HCV Intervention In Drug Treatment Settings - 1
This study has been completed.
Sponsor:
University of Colorado, Denver
Collaborator:
Oregon Health and Science University
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00102349
First received: January 27, 2005
Last updated: April 13, 2010
Last verified: April 2010
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | January 27, 2005 | ||||
| Last Updated Date | April 13, 2010 | ||||
| Start Date ICMJE | November 2004 | ||||
| Primary Completion Date | February 2006 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
HIV/HCV injection risk behaviors | ||||
| Original Primary Outcome Measures ICMJE | Not Provided | ||||
| Change History | Complete list of historical versions of study NCT00102349 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | HIV and HCV Intervention In Drug Treatment Settings - 1 | ||||
| Official Title ICMJE | HIV and HCV Intervention in Drug Treatment Settings | ||||
| Brief Summary | The purpose of this study is to test two strategies to reduce the risk of contracting Human Immunodeficiency Virus (HIV) or Hepatitis C Virus (HCV) by reducing risk behaviors in patients undergoing drug detoxification. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 3 | ||||
| Study Design ICMJE | Primary Purpose: Prevention | ||||
| Condition ICMJE | Behavior Therapy | ||||
| Intervention ICMJE | Behavioral: Behavior Therapy | ||||
| Study Arm (s) | Not Provided | ||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 706 | ||||
| Completion Date | February 2006 | ||||
| Primary Completion Date | February 2006 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Volunteers will be IV drug users already enrolled in drug detoxification treatment. |
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | United States | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT00102349 | ||||
| Other Study ID Numbers ICMJE | NIDA-CTN-0017-1 | ||||
| Has Data Monitoring Committee | Yes | ||||
| Responsible Party | Robert Booth, Ph.D., University of Colorado at Denver | ||||
| Study Sponsor ICMJE | University of Colorado, Denver | ||||
| Collaborators ICMJE | Oregon Health and Science University | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | National Institute on Drug Abuse (NIDA) | ||||
| Verification Date | April 2010 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||